Home/ Crypto News/ GSK (GSK) Stock Gains Following Berenberg Analyst Upgrade and $750M Chimagen Acquisition

blockonomi 3 days ago

GSK (GSK) Stock Gains Following Berenberg Analyst Upgrade and $750M Chimagen Acquisition

Stocks

GSK stock increased 0.4% following Berenberg's upgrade to buy with £22 target and announcement of $750M Chimagen deal for multiple myeloma therapy.

The post GSK (GSK) Stock Gains Following Berenberg Analyst Upgrade and $750M Chimagen Acquisition appeared first on Blockonomi.

Source: Source: Blockonomi